Next Article in Journal
A Functional K+ Channel from Tetraselmis Virus 1, a Member of the Mimiviridae
Next Article in Special Issue
Pseudotyping Lentiviral Vectors: When the Clothes Make the Virus
Previous Article in Journal
Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
Previous Article in Special Issue
The Old and the New: Prospects for Non-Integrating Lentiviral Vector Technology

Gene Therapy Applications of Non-Human Lentiviral Vectors

Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DU, UK
Viruses 2020, 12(10), 1106;
Received: 21 August 2020 / Revised: 23 September 2020 / Accepted: 25 September 2020 / Published: 29 September 2020
(This article belongs to the Special Issue Lentiviral Vectors)
Recent commercialization of lentiviral vector (LV)-based cell therapies and successful reports of clinical studies have demonstrated the untapped potential of LVs to treat diseases and benefit patients. LVs hold notable and inherent advantages over other gene transfer agents based on their ability to transduce non-dividing cells, permanently transform target cell genome, and allow stable, long-term transgene expression. LV systems based on non-human lentiviruses are attractive alternatives to conventional HIV-1-based LVs due to their lack of pathogenicity in humans. This article reviews non-human lentiviruses and highlights their unique characteristics regarding virology and molecular biology. The LV systems developed based on these lentiviruses, as well as their successes and shortcomings, are also discussed. As the field of gene therapy is advancing rapidly, the use of LVs uncovers further challenges and possibilities. Advances in virology and an improved understanding of lentiviral biology will aid in the creation of recombinant viral vector variants suitable for translational applications from a variety of lentiviruses. View Full-Text
Keywords: gene therapy; lentivirus; lentiviral vector; HIV-1; SIV; FIV; EIAV; non-primate lentivirus gene therapy; lentivirus; lentiviral vector; HIV-1; SIV; FIV; EIAV; non-primate lentivirus
Show Figures

Figure 1

MDPI and ACS Style

Munis, A.M. Gene Therapy Applications of Non-Human Lentiviral Vectors. Viruses 2020, 12, 1106.

AMA Style

Munis AM. Gene Therapy Applications of Non-Human Lentiviral Vectors. Viruses. 2020; 12(10):1106.

Chicago/Turabian Style

Munis, Altar M. 2020. "Gene Therapy Applications of Non-Human Lentiviral Vectors" Viruses 12, no. 10: 1106.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop